Adrenocortical adenoma

Last updated
Adrenocortical Adenoma
Other namesAdrenal cortical adenoma, adrenal adenoma
Adrenal gland Conn syndrome4.jpg
Adrenal adenoma in a patient with Conn syndrome
Specialty Endocrinology, oncology   OOjs UI icon edit-ltr-progressive.svg

An adrenocortical adenoma or adrenal adenoma is commonly described as a benign neoplasm emerging from the cells that comprise the adrenal cortex. Like most adenomas, the adrenocortical adenoma is considered a benign tumor since the majority of them are non-functioning and asymptomatic. Adrenocortical adenomas are classified as ACTH-independent disorders, and are commonly associated with conditions linked to hyperadrenalism such as Cushing's syndrome (hypercortisolism) or Conn's syndrome (hyperaldosteronism), which is also known as primary aldosteronism. [1] In addition, recent case reports further support the affiliation of adrenocortical adenomas with hyperandrogenism or florid hyperandrogenism which can cause hyperandrogenic hirsutism in females. [2] "Cushing's syndrome" differs from the "Cushing's disease" even though both conditions are induced by hypercortisolism. The term "Cushing's disease" refers specifically to "secondary hypercortisolism" classified as "ACTH-dependent Cushing's syndrome" caused by pituitary adenomas. In contrast, "Cushing's syndrome" refers specifically to "primary hypercortisolism" classified as "ACTH-independent Cushing's syndrome" caused by adrenocortical adenomas.

Contents

Presentation

Hypercortisolism
Hypercortisolism.png
Specialty Endocrinology, oncology   OOjs UI icon edit-ltr-progressive.svg
Symptoms Adrenal Lesion

Adrenal adenomas are often categorized as endocrine-inactive tumors considering that majority of them are non-functioning and asymptomatic. Functional adrenocortical adenomas demonstrate symptoms consistent with mixed endocrine syndromes. In most reported cases of adrenocortical adenoma, patients have presented with one or multiple endocrine syndromes such as hyperaldosteronism/Conn's Syndrome, [3] hypercortisolism/Cushing's syndrome, [4] hyperandrogenism/feminization, [2] virilization, [5] or hirsutism. [6] Some of the common symptoms associated with adrenocortical adenomas include:

Musculoskeletal

Cardiovascular

Endocrine and Metabolic

→More prevalent in males

→More prevalent in females

Neuropsychological

Skin

Cause

Adrenal Glands Zonations
Antinkscio sandara.png
Specialty Endocrinology, oncology   OOjs UI icon edit-ltr-progressive.svg
Adrenal Glands Zonations
1818 The Adrenal Glands.jpg
Specialty Endocrinology, oncology   OOjs UI icon edit-ltr-progressive.svg

Study of the reported cases indicate that most adrenocortical adenomas occur due to neoplastic proliferation of adrenal cortical cells within the three distinct layers of adrenal cortex. In humans, the adrenal cortex comprises three concentric zones including the zona glomerulosa, zona fasciculata, and zona reticularis that under normal conditions respond to body's physiological demands for steroid hormones. The adrenal cortex is considered a dynamic organ in which senescent cells are replaced by newly differentiated cells. This constant renewal facilitates organ remodeling which contributes to dynamic characteristics of the adrenal cortex. [7] correspondingly, the developmental physiology of the adrenal cortex is believed to play a pivotal role in formation of the adrenocortical tumors. Hence, the molecular mechanisms involved in normal development of the adrenal glands are like double edged swords that can lead to the formation of tumors within the adrenal cortex. Moreover, recent studies suggest that mutations affecting the molecular pathways of the adrenocortical region can stimulate abnormal proliferation and tumor formation. Through these studies, the cyclic AMP-dependent protein kinase A signaling has been identified as a key mediator of cortisol secretion, and the mutations associated with the dysregulation of cyclic AMP - protein kinase A pathways have been implicated in the adrenocortical pathophysiology. [8]

Pathophysiology

If functional, adrenocortical adenomas can affect the normal activities of the adrenal cortex. Located within the adrenal glands are the three zones that are responsible for secretion of the three major classes of adrenal steroids. Hence, functional adrenocortical adenomas can induce over-secretion of adrenal steroids associated with pure or mixed endocrine syndromes, a condition commonly known as hyperadrenalism.[ citation needed ]

Diagnosis

Due to their asymptomatic nature, most reported cases of adrenal adenomas have been discerned fortuitously through autopsy, or during medical imaging, particularly CT scan (computed tomography) and magnetic resonance imaging. Hence, they have earned the title incidentaloma referring to small adenoma discovered incidentally. [9] Though adrenocortical adenomas are considered challenging to differentiate from the normal adrenal cortex, they appear as well-circumscribed lesions once isolated. [ citation needed ]

Imaging Diagnostics

Adrenal-dedicated CT and MRI imaging can be performed to distinguish benign adenomas from potentially malignant lesions. [10] Online calculators assist radiologists in calculating the washout of contrast in adrenal nodules on CT [11] and chemical shift on MRI [12] .

Laboratory Tests

Gross Description

(may have focal dark regions corresponding to hemorrhage, lipid-depletion, and increased lipofuscin) [9]

Histopathology

Zona fasciculata versus adrenocortical adenoma. An adrenocortical adenoma typically has mild changes in comparison, including larger cells with larger and more pleomorphic nuclei with more coarse chromatin. H&E stain. Zona fasciculata versus adrenocortical adenoma.jpg
Zona fasciculata versus adrenocortical adenoma. An adrenocortical adenoma typically has mild changes in comparison, including larger cells with larger and more pleomorphic nuclei with more coarse chromatin. H&E stain.

The microscopic histopathology analysis of the tissue samples obtained from the adrenal cortex of individuals presenting with adenoma-associated symptoms such as primary aldestronism (PA) indicates that adenoma cells are relatively larger with different cytoplasm, and increased variation in nuclear size. This indication is based on comparison between the healthy (normal) and affected (adenoma-associated) adrenal cortex tissue samples. [ citation needed ]

Adrenocortical adenomas are most commonly distinguished from adrenocortical carcinomas (their malignant counterparts) by the Weiss system, [13] as follows: [14]

Characteristic [14] Score
High nuclear grade (enlarged, oval to lobated, with coarsely granular to hyperchromatic chromatin and easily discernible, prominent nucleoli) [15] 1
More mitoses than 5/50 high power fields1
Atypical mitoses1
Eosinophilic cytoplasm in >75% of tumor cells1
Diffuse architecture of >33% of tumor1
Necrosis1
Venous invasion1
Sinusoidal invasion (no smooth muscle in wall)1
Capsular invasion1

Total score indicates: [14]

Treatment

In order to acquire better treatment strategies, it is important to further examine, study and discern the distinct molecular mechanisms involved in the formation of endogenous Adrenal Adenomas, hyperplasias, and ACTH-independent Cushing's Syndrome to improve the available diagnostic and prognostic markers that can assist clinicians in the management and advance-treatment of such conditions. [16]

A 2018 Cochrane Systematic review compared two different types of surgery: laparoscopic retroperotenial adrenalectomy and laporoscopic transperitoenal adrenelectomy in different types of adrenal tumors. [17] Laparoscopic retroperotenial adrenalectomy appeared to reduce late morbility, time to oral fluid or food intake and time to ambulation, when compared to laparoscopic transperitoenal adrenalectomy. [17] However there was uncertainty in these findings due to low-quality evidence, as well as inconclusive findings about effects of either surgery on all-cause mortality, early morbidity, socioeconomic effects, duration of surgery, operative blood loss, conversion to open surgery. [17]

Prognosis

Epidemiology

Incidences and prognoses of adrenal tumors, with adrenocortical adenoma at left. Incidences and prognoses of adrenal tumors.png
Incidences and prognoses of adrenal tumors, with adrenocortical adenoma at left.

See also

References

  1. "Definition: adrenocortical adenoma from Online Medical Dictionary".
  2. 1 2 LaVoie, Melanie; Constantinides, Vasilis; Robin, Noel; Kyriacou, Angelos (30 July 2018). "Florid hyperandrogenism due to a benign adrenocortical adenoma". BMJ Case Reports. 2018: bcr-2018-224804. doi:10.1136/bcr-2018-224804. PMC   6067132 . PMID   30061126.
  3. Wang, Wei; Wei, Feng; Li, RanHao; Tian, JiaHui (October 2019). "A case report of idiopathic hyperaldosteronism characterized by bilateral adrenal adenoma". Medicine. 98 (43): e17418. doi:10.1097/MD.0000000000017418. PMC   6824822 . PMID   31651844.
  4. Ren, Kaiyun; Wei, Jia; Liu, Qilin; Zhu, Yuchun; Wu, Nianwei; Tang, Ying; Li, Qianrui; Zhang, Qianying; Yu, Yerong; An, Zhenmei; Chen, Jing; Li, Jianwei (17 June 2019). "Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report". BMC Endocrine Disorders. 19 (1): 63. doi: 10.1186/s12902-019-0395-y . PMC   6580498 . PMID   31208392.
  5. Kobayashi, Toshihiro; Imachi, Hitomi; Sato, Seisuke; Ibata, Tomohiro; Fukunaga, Kensaku; Yoshimoto, Takuo; Kikuchi, Fumi; Yonezaki, Kazuko; Yamaji, Nao; Lyu, Jingya; Dong, Tao; Nagata, Hiromi; Kadota, Kyuichi; Kushida, Yoshio; Haba, Reiji; Murao, Koji (1 February 2019). "Bilateral Adrenocortical Adenomas along with Virilization and Cushing's Syndrome". Internal Medicine. 58 (3): 405–409. doi:10.2169/internalmedicine.0790-18. PMC   6395137 . PMID   30210105.
  6. Rodríguez-Gutiérrez, René; Bautista-Medina, Mario Arturo; Teniente-Sanchez, Ana Eugenia; Zapata-Rivera, Maria Azucena; Montes-Villarreal, Juan (2013). "Pure Androgen-Secreting Adrenal Adenoma Associated with Resistant Hypertension". Case Reports in Endocrinology. 2013: 356086. doi: 10.1155/2013/356086 . PMC   3681270 . PMID   23819074.
  7. Pihlajoki, Marjut; Dörner, Julia; Cochran, Rebecca S.; Heikinheimo, Markku; Wilson, David B. (5 March 2015). "Adrenocortical Zonation, Renewal, and Remodeling". Frontiers in Endocrinology. 6: 27. doi: 10.3389/fendo.2015.00027 . PMC   4350438 . PMID   25798129.
  8. Lodish, Maya (June 2017). "Genetics of Adrenocortical Development and Tumors". Endocrinology and Metabolism Clinics of North America. 46 (2): 419–433. doi:10.1016/j.ecl.2017.01.007. PMC   5424622 . PMID   28476230.
  9. 1 2 Lloyd, Ricardo V. (April 2011). "Adrenal cortical tumors, pheochromocytomas and paragangliomas". Modern Pathology. 24: S58–65. doi: 10.1038/modpathol.2010.126 . PMID   21455202.
  10. Nandra, Gurinder; Duxbury, Oliver; Patel, Pawan; Patel, Jaymin H.; Patel, Nirav; Vlahos, Ioannis (July 2020). "Technical and Interpretive Pitfalls in Adrenal Imaging". RadioGraphics. 40 (4): 1041–1060. doi:10.1148/rg.2020190080. ISSN   0271-5333.
  11. "Adrenal Washout Calculator + Report Generator". radathand.com. Retrieved 2025-07-31.
  12. "Adrenal MRI Calculator For Chemical Shift - Rad At Hand". radathand.com. Retrieved 2025-07-31.
  13. Wang, Cuiping; Sun, Yang; Wu, Huanwen; Zhao, Dachun; Chen, Jie (2014). "Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers". Histopathology. 64 (4): 567–576. doi:10.1111/his.12283. ISSN   0309-0167. PMC   4282325 . PMID   24102952.
  14. 1 2 3 Aye, Than Than; Myint, Phone; Myint, Kyar Nyo Soe (2015). "Adrenocortical Oncocytoma Presenting with Gynaecomastia". Journal of the ASEAN Federation of Endocrine Societies. 30 (1): 27–30. doi: 10.15605/jafes.030.01.08 . ISSN   0857-1074.
  15. Tito Fojo (26 December 2016). "Adrenocortical Cancer" . Retrieved 2020-07-02.
  16. Bourdeau, Isabelle; Lampron, Antoine; Costa, Marcia Helena Soares; Tadjine, Mimi; Lacroix, André (June 2007). "Adrenocorticotropic hormone-independent Cushing's syndrome". Current Opinion in Endocrinology, Diabetes and Obesity. 14 (3): 219–225. doi:10.1097/MED.0b013e32814db842. PMID   17940443. S2CID   40454423.
  17. 1 2 3 Arezzo, Alberto; Bullano, Alberto; Cochetti, Giovanni; Cirocchi, Roberto; Randolph, Justus; Mearini, Ettore; Evangelista, Andrea; Ciccone, Giovannino; Bonjer, H. Jaap; Morino, Mario (2018-12-30). Cochrane Metabolic and Endocrine Disorders Group (ed.). "Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults". Cochrane Database of Systematic Reviews. 2018 (12): CD011668. doi:10.1002/14651858.CD011668.pub2. PMC   6517116 . PMID   30595004.
  18. Data and references for pie chart are located at file description page in Wikimedia Commons.